Controlled and treatment of opiate-requiring pain using biosensors.

Reference number
Coordinator Sensidose Aktiebolag
Funding from Vinnova SEK 1 228 500
Project duration March 2019 - December 2020
Status Ongoing
Venture Innovationsprojekt i företag 2018
Call Innovationsprojekt i företag - hösten 2018

Purpose and goal

The project aims to objectively register pain in real-time, evaluate whether objective physiological pain signals are consistent with subjectively perceived pain and use this knowledge to develop an algorithm for how to dose pain medication reflecting physiological signals in the future. Initially, the goal is to be able to measure pain in non-hospital environment in real-time, using objectively registered pain signs. The goal, in the long term, is also to contribute to a better opiate use in the home environment, thereby reducing abuse tendencies.

Expected results and effects

The expected effects are to be able to - Offer healthcare providers an opportunity for improved control and follow-up of treatment of severe pain with opiates - Offer patients a complement to current treatment that solely takes into account subjective pain. For example, patients requiring large doses of medication to control pain, can demonstrate their need by the presence of objective physiological pain parameters - Enable sensor guided pain treatment, ie a treatment where physiological signals control the treatment regimen.

Planned approach and implementation

The following steps will be implemented: 1). Identify and choose among available data collection systems for sampling of physiological parameters. Set up the test system. 2). Transfer of the test method to the pain clinic/treatment centers. 3). Collection of data from patients with different types of pain (performed in hospital environment) 4). Analysis and work out algorithms 5). Business Analysis

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 19 March 2019

Reference number 2018-05203

Page statistics